Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma.

about

Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma

P2860

Q58617727-6F41C2D8-F694-4D52-869A-1C840AFAC84F

P2860

Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma.

Item

http://www.wikidata.org/entity/Q54977082

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Bromodomain protein BRD4 inhib ...... advanced renal cell carcinoma.

@en

Bromodomain protein BRD4 inhib ...... advanced renal cell carcinoma.

@nl

type

Item

label

Bromodomain protein BRD4 inhib ...... advanced renal cell carcinoma.

@en

Bromodomain protein BRD4 inhib ...... advanced renal cell carcinoma.

@nl

prefLabel

Bromodomain protein BRD4 inhib ...... advanced renal cell carcinoma.

@en

Bromodomain protein BRD4 inhib ...... advanced renal cell carcinoma.

@nl

P1476

Bromodomain protein BRD4 inhib ...... advanced renal cell carcinoma.

@en

P2093

Hideki Enokida

http://www.w3.org/2001/XMLSchema#string

Hirofumi Yoshino

http://www.w3.org/2001/XMLSchema#string

Kazutaka Miyamoto

http://www.w3.org/2001/XMLSchema#string

Makiko Meguro-Horike

http://www.w3.org/2001/XMLSchema#string

Masaya Yonemori

http://www.w3.org/2001/XMLSchema#string

Masayuki Nakagawa

http://www.w3.org/2001/XMLSchema#string

Satoshi Sugita

http://www.w3.org/2001/XMLSchema#string

Shin-Ichi Horike

http://www.w3.org/2001/XMLSchema#string

Takashi Sakaguchi

http://www.w3.org/2001/XMLSchema#string

Yoichi Osako

http://www.w3.org/2001/XMLSchema#string

P2860

Selective inhibition of BET bromodomains

Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer

SPOC: a widely distributed domain associated with cancer, apoptosis and transcription

On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

Rac activation and inactivation control plasticity of tumor cell movement

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.

Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors.

P304

23003-23017

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25190

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29796168

http://www.w3.org/2001/XMLSchema#string

P932

5955408

http://www.w3.org/2001/XMLSchema#string

Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma.

about

P2860

P2860

Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932